These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4083910)

  • 1. Induction of urinary bladder hyperplasia in Sprague-Dawley rats orally administered tri-n-butyl phosphate.
    Laham S; Broxup B; Long G
    Arch Environ Health; 1985; 40(6):301-6. PubMed ID: 4083910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subacute oral toxicity of tri-n-butyl phosphate in the Sprague-Dawley rat.
    Laham S; Long G; Broxup B
    J Appl Toxicol; 1984 Jun; 4(3):150-4. PubMed ID: 6747197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dietary toxicity/oncogenicity study of tributyl phosphate in the rat.
    Auletta CS; Weiner ML; Richter WR
    Toxicology; 1998 Jul; 128(2):125-34. PubMed ID: 9710153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tributyl phosphate effects on urine and bladder epithelium in male Sprague-Dawley rats.
    Arnold LL; Christenson WR; Cano M; St John MK; Wahle BS; Cohen SM
    Fundam Appl Toxicol; 1997 Dec; 40(2):247-55. PubMed ID: 9441721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subchronic oral toxicity of tributoxyethyl phosphate in the Sprague-Dawley rat.
    Laham S; Broxup BR; Long GW
    Arch Environ Health; 1985; 40(1):12-7. PubMed ID: 3994415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity of tri-n-butyl phosphate, with special reference to organ weights, serum components and cholinesterase activity in male rats.
    Oishi H; Oishi S; Hiraga K
    Toxicol Lett; 1980 Jul; 6(2):81-5. PubMed ID: 7414624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity of several phosphoric acid esters in rats.
    Oishi H; Oishi S; Hiraga K
    Toxicol Lett; 1982 Sep; 13(1-2):29-34. PubMed ID: 7179306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dietary oncogenicity study of tributyl phosphate in the CD-1 mouse.
    Auletta CS; Kotkoskie LA; Saulog T; Richter WR
    Toxicology; 1998 Jul; 128(2):135-41. PubMed ID: 9710154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strain differences in N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis in rats.
    Nakanowatari J; Fukushima S; Imaida K; Ito N; Nagase S
    Jpn J Cancer Res; 1988 Apr; 79(4):453-9. PubMed ID: 3133335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicology and carcinogenesis studies of 3,3',4,4'-tetrachloroazobenzene (TCAB) (CAS No. 14047-09-7) in Harlan Sprague-Dawley rats and B6C3F1 mice (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2010 Nov; (558):1-206. PubMed ID: 21383777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summation effects of uracil and other promoters on epithelial lesion development in the F344 rat urinary bladder initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    de Camargo JL; Shirai T; Kato T; Asamoto M; Fukushima S
    Jpn J Cancer Res; 1991 Nov; 82(11):1220-5. PubMed ID: 1752781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of FT-207 on bladder cancer in rats induced by BBN. II: The effect of oral administration of FT-207 during oncogenesis of bladder cancer].
    Okajima E; Hiramatsu T; Kihoin K; Ijuin M; Hirao Y; Ohara S; Babaya K; Tanaka M; Maruyama Y
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):473-9. PubMed ID: 6820898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous treatment with benzyl isothiocyanate, a strong bladder promoter, inhibits rat urinary bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Okazaki K; Yamagishi M; Son HY; Imazawa T; Furukawa F; Nakamura H; Nishikawa A; Masegi T; Hirose M
    Nutr Cancer; 2002; 42(2):211-6. PubMed ID: 12416262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental administration of di-N-butyl-nitrosamine (DBN) in rats. Carcinogenic activity in the urinary bladder].
    Davaris P; Andrulakakis F; Patsouris E; Fitisa R; Papacharalampous NX
    Zentralbl Allg Pathol; 1983; 127(1-2):105-8. PubMed ID: 6858417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of TRI-n-butyl phosphate on pregnancy in rats.
    Noda T; Yamano T; Shimizu M; Morita S
    Food Chem Toxicol; 1994 Nov; 32(11):1031-6. PubMed ID: 7959457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-ascorbic acid amplification of bladder carcinogenesis promotion by K2CO3.
    Fukushima S; Kurata Y; Hasegawa R; Asamoto M; Shibata MA; Tamano S
    Cancer Res; 1991 May; 51(10):2548-51. PubMed ID: 2021935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strain differences in sensitivity to the promoting effect of sodium L-ascorbate in a two-stage rat urinary bladder carcinogenesis model.
    Murai T; Mori S; Hosono M; Takashima A; Machino S; Oohara T; Yamashita H; Makino S; Matsuda T; Wanibuchi H; Fukushima S
    Jpn J Cancer Res; 1997 Mar; 88(3):245-53. PubMed ID: 9140108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orally administered nicotine effects on rat urinary bladder proliferation and carcinogenesis.
    Suzuki S; Cohen SM; Arnold LL; Kato H; Fuji S; Pennington KL; Nagayasu Y; Naiki-Ito A; Yamashita Y; Takahashi S
    Toxicology; 2018 Apr; 398-399():31-40. PubMed ID: 29501575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicology and carcinogenesis studies of pulegone (CAS No. 89-82-7) in F344/N rats and B6C3F1 mice (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2011 Aug; (563):1-201. PubMed ID: 21921962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.